Lineage Cell Therapeutics financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$0.69M $0.90M $1.16M $1.05M $1.50M $1.93M $3.71M $4.43M $3.92M $4.43M $5.24M $7.04M $5.92M $3.46M $4.99M $3.52M $1.83M $4.34M $14.70M $8.95M $0.00M
GM % Gross Margin %
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 99.25% 98.21% 88.91% 82.12% 84.04% 84.27% 93.96% 95.14% 93.95% 88.28% 78.92% 67.15% 95.05% 92.50% 0.00%
OM Operating Margin
-278.81% -223.47% -150.76% -116.85% -187.70% -182.86% -265.70% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -129.16% -276.50% 0.00%
EPS Earnings Per Share
$-0.12 $-0.28 $-0.59 $-0.51 $-0.32 $-0.33 $-0.14 $-0.12 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
17.81m 17.87m 22.57m 22.83m 23.79m 33.31m 47.6m 48.95m 49.19m 64.89m 83.12m 90.42m 102.77m 126.87m 121.9m 149.79m 149.99m 168.56m 169.71m 174.99m 188.48m
OCF Operating Cash Flow
$-1.54M $-1.41M $-1.26M $-1.24M $-1.60M $-4.26M $-7.73M $-13.59M $-19.68M $-29.51M $-38.85M $-44.54M $-42.33M $-30.52M $-30.88M $-31.95M $-19.75M $-23.56M $1.06M $-28.57M $0.00M
FCF Free Cash Flow
$0.00M $0.00M $-1.27M $-1.25M $-1.71M $-4.32M $-7.95M $-14.55M $-20.08M $-33.14M $-39.55M $-49.87M $-44.57M $-31.85M $-32.30M $-32.39M $-19.81M $-23.91M $0.65M $-37.00M $0.00M
FCFS Free Cash Flow Per Share
$-0.09 $-0.08 $-0.06 $-0.05 $-0.10 $-0.15 $-0.20 $-0.31 $-0.41 $-0.61 $-0.60 $-0.63 $-0.46 $-0.28 $-0.27 $-0.22 $-0.13 $-0.15 $0.00 $-0.17 $0.00